Applied Therapeutics Inc (APLT)
4.28
+0.05
(+1.18%)
USD |
NASDAQ |
Apr 26, 16:00
4.29
+0.01
(+0.23%)
After-Hours: 20:00
Applied Therapeutics Enterprise Value: 403.61M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 403.61M |
| April 25, 2024 | 398.31M |
| April 24, 2024 | 406.78M |
| April 23, 2024 | 422.67M |
| April 22, 2024 | 417.37M |
| April 19, 2024 | 414.20M |
| April 18, 2024 | 452.32M |
| April 17, 2024 | 461.85M |
| April 16, 2024 | 495.73M |
| April 15, 2024 | 486.20M |
| April 12, 2024 | 496.79M |
| April 11, 2024 | 515.85M |
| April 10, 2024 | 532.79M |
| April 09, 2024 | 540.20M |
| April 08, 2024 | 549.73M |
| April 05, 2024 | 562.44M |
| April 04, 2024 | 577.26M |
| April 03, 2024 | 607.97M |
| April 02, 2024 | 624.91M |
| April 01, 2024 | 620.68M |
| March 28, 2024 | 670.44M |
| March 27, 2024 | 675.74M |
| March 26, 2024 | 656.68M |
| March 25, 2024 | 665.15M |
| March 22, 2024 | 665.15M |
| Date | Value |
|---|---|
| March 21, 2024 | 673.09M |
| March 20, 2024 | 681.03M |
| March 19, 2024 | 613.26M |
| March 18, 2024 | 581.50M |
| March 15, 2024 | 587.85M |
| March 14, 2024 | 566.67M |
| March 13, 2024 | 597.38M |
| March 12, 2024 | 586.79M |
| March 11, 2024 | 621.73M |
| March 08, 2024 | 684.21M |
| March 07, 2024 | 651.38M |
| March 06, 2024 | 634.44M |
| March 05, 2024 | 603.73M |
| March 04, 2024 | 572.11M |
| March 01, 2024 | 587.43M |
| February 29, 2024 | 591.93M |
| February 28, 2024 | 617.16M |
| February 27, 2024 | 453.18M |
| February 26, 2024 | 427.95M |
| February 23, 2024 | 467.59M |
| February 22, 2024 | 425.68M |
| February 21, 2024 | 385.79M |
| February 20, 2024 | 401.07M |
| February 16, 2024 | 407.01M |
| February 15, 2024 | 268.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-41.24M
Minimum
Mar 14 2022
1.164B
Maximum
Feb 05 2020
250.37M
Average
176.17M
Median
Enterprise Value Benchmarks
| Sarepta Therapeutics Inc | 11.65B |
| Fate Therapeutics Inc | 61.93M |
| Viking Therapeutics Inc | 7.231B |
| Terns Pharmaceuticals Inc | 54.00M |
| Edgewise Therapeutics Inc | 1.187B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -37.68M |
| Revenue (Quarterly) | -0.667M |
| Total Expenses (Quarterly) | 20.34M |
| EPS Diluted (Quarterly) | -0.33 |
| Earnings Yield | -31.54% |
| Normalized Earnings Yield | -17.34 |